BIOA
BioAge Labs Inc.

485
Mkt Cap
$814.59M
Volume
437.00
52W High
$24.00
52W Low
$2.88
PE Ratio
-9.03
BIOA Fundamentals
Price
$19.10
Prev Close
$19.51
Open
$19.49
50D MA
$13.82
Beta
1.23
Avg. Volume
460,597.73
EPS (Annual)
-$1.98
P/B
2.47
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
BioAge Labs (NASDAQ:BIOA) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen lowered shares of BioAge Labs from a "hold" rating to a "sell" rating in a research note on Monday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
BioAge Labs (NASDAQ:BIOA) Stock Price Down 4.1% - Here's What Happened
BioAge Labs (NASDAQ:BIOA) Stock Price Down 4.1% - Here's Why...
MarketBeat·8d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Time to Sell?
BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Here's What Happened...
MarketBeat·9d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of BioAge Labs from a "sell" rating to a "hold" rating in a research note on Sunday...
MarketBeat·12d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Shares Down 6.1% on Insider Selling
BioAge Labs (NASDAQ:BIOA) Trading Down 6.1% Following Insider Selling...
MarketBeat·14d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) CEO Kristen Fortney Sells 233,107 Shares
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) CEO Kristen Fortney sold 233,107 shares of the company's stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price...
MarketBeat·14d ago
News Placeholder
Dov Md Goldstein Sells 27,000 Shares of BioAge Labs (NASDAQ:BIOA) Stock
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) CFO Dov Md Goldstein sold 27,000 shares of the company's stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price...
MarketBeat·15d ago
News Placeholder
Insider Selling: BioAge Labs (NASDAQ:BIOA) CEO Sells 233,107 Shares of Stock
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) CEO Kristen Fortney sold 233,107 shares of the business's stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of...
MarketBeat·15d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Reaches New 1-Year High - Should You Buy?
BioAge Labs (NASDAQ:BIOA) Reaches New 52-Week High - What's Next...
MarketBeat·18d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Hits New 12-Month High - Time to Buy?
BioAge Labs (NASDAQ:BIOA) Hits New 12-Month High - Here's Why...
MarketBeat·23d ago
<
1
2
...
>

Latest BIOA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.